JPRN-jRCT2080221462未知3 期
Phase III Confirmatory Study ; Comparison of efficacy and safety of paricalcitol injection with maxacalcitol injection in adult Japanese chronic kidney disease subjects receiving hemodialysis with secondary hyperparathyroidism
Abbott Japan Co., Ltd.0 个研究点目标入组 252 人开始时间: 2011年5月18日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 252
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Adult Chronic Kidney Disease (CKD) Stage 5 patient with
- •-intact parathyroid hormone (iPTH) greater than or equal to 300pg/mL
- •-adjusted normalized serum total calcium (Ca) greater than or equal to 8.4 - less then 10.2 mg/dL
- •-serum phosphorus (P) less than or equal to 6.5 mg/d
排除标准
- •Patients taking drugs that affect iPTH, calcium or bone metabolism
研究者
相似试验
进行中（未招募）
不适用
Enterogermina (Bacillus Clausii ) in the management of Diarrhea in childreMedDRA version: 17.1Level: LLTClassification code 10000706Term: Acute diarrheaSystem Organ Class: 100000004856Acute diarrheaEUCTR2014-004636-19-Outside-EU/EEASanofi Aventis264
招募中
1 期
A study to compare nemtabrutinib to standard cancer treatments in people with untreated blood cancerChronic lymphocytic leukemia/ small lymphocytic lymphomaMedDRA version: 21.1Level: LLTClassification code: 10003910Term: B-cell small lymphocytic lymphoma NOS Class: 10029104MedDRA version: 21.0Level: LLTClassification code: 10008976Term: Chronic lymphocytic leukemia Class: 10029104CTIS2022-501481-21-00Merck Sharp & Dohme LLC212
进行中（未招募）
不适用
A Phase III Safety and Efficacy Study to Compare Immune Responses following Injection with Either Two Doses of HEPLISAV™ or Three Doses of Engerix-B®Prevention of Hepatitis B Virus (HBV) infection.MedDRA version: 9.1Level: LLTClassification code 10054181Term: Hepatitis B immunizationEUCTR2006-006743-31-DEDynavax Technologies Corporation2,400
已完成
不适用
Comparison of the efficacy and safety of platelet-rich-plasma and autologous-serum eye drops in primary Sjögren syndrome dry eyesDiseases of the musculoskeletal system and connective tissueKCT0008103The Catholic University of Korea, Seoul St. Mary's Hospital36
已完成
3 期
PROphylaxis of ThromboEmbolism in Critical Care Trial (PROTECT)ThromboembolismCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12606000090516McMaster University3,650